Marek Health vs PeterMD: Which TRT Clinic Deserves Your Money?

Marek Health and PeterMD both sit above the budget tier of telehealth TRT — neither is chasing the $99/month crowd. But they got there from different directions. Marek built its reputation on going deeper than anyone else: 130+ biomarker panels, root-cause protocols, and a founder (Derek from More Plates More Dates) known for picking apart clinical literature. PeterMD built its reputation on a narrower promise, done well: board-certified physicians, real video consultations, and a straightforward testosterone cypionate protocol.

Quick Answer

Marek Health is the more comprehensive service and earns the higher Freak Score (8.2 vs. 7.4), largely because of its diagnostic depth and broader medication menu. PeterMD costs less, guarantees board-certified (not just licensed) physicians, and delivers a genuinely thorough — if narrower — TRT experience for around $900-$1,500 less per year. Which one wins depends on whether you're optimizing for depth or for a reliably good, more affordable testosterone protocol.


Marek Health vs PeterMD: Side-by-Side Comparison

Feature Marek Health PeterMD
Pricing model $250 onboarding + a la carte Flat $199/month, all-in
Typical annual cost $3,300-$3,900/yr ~$2,388/yr
Physician credential Licensed physicians Board-certified physicians
Biomarkers tested 50-130+ ~11 (thyroid, DHEA-S, IGF-1 included)
Consultation format Data-driven review with PCC + physician Live video call (20-30 min)
Medication options TRT, enclomiphene, peptides, GLP-1s, hair loss, 500+ therapies Primarily testosterone cypionate
Delivery cadence Ongoing, protocol-dependent Quarterly (12-week supply)
Insurance accepted No (HSA/FSA eligible) No (HSA/FSA eligible)
Trustpilot rating 5.0 (875+ reviews) Not independently verified at this depth
Freak Score 8.2/10 7.4/10
Best for Comprehensive optimization, complex cases Straightforward TRT with strong credentials

Key Differences Between Marek Health and PeterMD

1. Price and Structure

PeterMD's pricing is dead simple: $199 a month, flat, covers the physician, labs, medication, and supplies. Marek's pricing is a la carte — a $250 onboarding deposit, then $250-$850 per lab panel (2-3 times a year), roughly $250 per provider consultation, and $100-$150/month for medication. Add it up and a typical Marek patient spends $3,300-$3,900 a year, versus PeterMD's predictable $2,388. PeterMD wins on both cost and pricing clarity — you know exactly what you're paying before you start, which Marek's a la carte structure doesn't offer.

2. Physician Credentials

This is PeterMD's headline differentiator: every prescribing physician is board-certified, which you can independently verify through the American Board of Medical Specialties' Certification Matters lookup. Marek employs licensed physicians, which is a legitimate and common standard in telehealth, but the company doesn't market board certification as a blanket guarantee the way PeterMD does. If having a board-certified physician specifically is non-negotiable for you, PeterMD wins on credential transparency, even though Marek's physicians are qualified to manage hormone therapy.

3. Diagnostic Depth

Here Marek pulls dramatically ahead. Its Comprehensive and Complete panels test 100-130+ biomarkers — thyroid, inflammatory markers, lipid subfractions, ApoB, full micronutrient status — on top of the standard hormone panel. PeterMD's initial workup is broader than budget competitors (it notably includes thyroid markers, DHEA-S, and IGF-1, which many providers skip), but it tops out around 11 markers, nowhere near Marek's ceiling. If your symptoms could have more than one root cause, Marek wins decisively here. If you want to sanity-check your own numbers before booking with either clinic, our breakdown of at-home testosterone tests covers which kits are accurate enough to trust as a starting point.

4. Consultation Format

PeterMD conducts actual video consultations — 20 to 30 minutes of live, face-to-screen time with your physician, which is more direct interaction than many competitors offer at any price point. Marek's process is more staged: a Patient Care Coordinator handles intake first, then a physician reviews your full panel and builds a protocol, with the emphasis on data interpretation over live conversation time. Both are legitimate approaches, but if you specifically want real-time dialogue with the physician managing your care, PeterMD wins. If you'd rather your physician spend their time interpreting 130 data points than talking through a call, Marek wins.

5. Medication Menu

Marek's treatment menu is dramatically broader — TRT, enclomiphene, peptide therapy (BPC-157 and others), GLP-1 agonists, and a compounded hair loss topical, with access to 500+ therapies depending on what your labs indicate. PeterMD is primarily built around testosterone cypionate; if you want enclomiphene or HCG as an alternative or adjunct, PeterMD's site doesn't clearly outline a pathway for that. Marek wins for anyone who wants more than a single-hormone protocol.

6. Delivery Cadence

PeterMD ships medication quarterly — a 12-week supply per shipment, which means fewer transactions and less risk of running out between refills, at the cost of a larger upfront commitment each time. Marek's delivery cadence is tied to your specific protocol and follow-up schedule rather than a fixed quarterly model. Neither approach is objectively better; it comes down to whether you prefer PeterMD's predictable quarterly rhythm or Marek's more individualized cadence.

7. Treatment Beyond Testosterone Cypionate

If you want anything other than standard testosterone cypionate, the gap widens further. PeterMD's public offering doesn't clearly outline a pathway to enclomiphene or HCG, which matters if you want to preserve fertility or prefer starting with a SERM before committing to exogenous testosterone. Marek offers enclomiphene as a standard alternative, along with HCG and aromatase inhibitors as clinically indicated, giving physicians more tools to fine-tune a protocol rather than defaulting to one medication for everyone. Marek wins for patients who want options beyond the standard injectable.

Understanding Why Monitoring Cadence Matters

Both clinics' approach to follow-up bloodwork isn't just administrative — it reflects real clinical guidelines. The Endocrine Society's 2018 practice guidelines recommend checking testosterone and hematocrit 3-6 months after starting therapy and then annually, specifically because testosterone replacement can raise red blood cell count (erythrocytosis) and affect PSA and lipid markers over time. That monitoring cadence matters even more in light of the TRAVERSE trial (NEJM, 2023) — the largest randomized safety study of TRT to date — which found no increased cardiovascular risk from testosterone therapy itself, but confirmed the hematocrit and lipid effects that make routine bloodwork non-negotiable. PeterMD builds this into its quarterly model — testing at 8-10 weeks initially, then every 3-6 months. Marek's cadence is similar but tied more tightly to your specific panel history, since a patient with more markers being tracked (thyroid, inflammatory, metabolic) may have more reasons to retest sooner than the standard hormone-only schedule. Neither company skips this step, which is the baseline you should expect from any legitimate TRT provider — if a clinic offers testosterone without a monitoring plan, that's a red flag regardless of price.

Similarities

Both clinics require confirmed low testosterone via bloodwork before prescribing, both use licensed medical providers, both ship medication directly to your door, and neither accepts insurance (though both work with HSA/FSA). Both also require ongoing monitoring — Marek at 3-6 month intervals, PeterMD at 8-10 weeks initially then every 3-6 months — which reflects the Endocrine Society's recommended cadence for hematocrit and lipid tracking on testosterone therapy. Neither is a bargain-basement option; both sit in the upper half of the telehealth TRT market on price.

Price and Value Analysis

Per year, PeterMD saves you roughly $900-$1,500 compared to Marek. What you give up for that savings is diagnostic breadth: Marek's ability to catch a sluggish thyroid, elevated inflammatory markers, or insulin resistance alongside low testosterone simply isn't matched by PeterMD's narrower panel. If your case is a straightforward testosterone deficiency and you want a board-certified physician managing it carefully, PeterMD delivers strong value at a meaningfully lower price. If you suspect there's more going on than testosterone alone — or you've already tried a provider like PeterMD or Hims and didn't get full answers — Marek's premium starts to look justified.

For the full competitive landscape, see our best online TRT clinics guide, and our Hims vs Marek Health comparison if you're also weighing a lower-cost DTC option against Marek.

Who Should Buy Marek Health

Marek is the right call if you've already been through a standard TRT workup and didn't get full answers, if you want peptide therapy or GLP-1 support alongside hormone optimization, or if you're the type of patient who wants your physician analyzing 130 data points, not 15. Read our full Marek Health review for the complete cost and protocol breakdown.

Who Should Buy PeterMD

PeterMD is the better fit if you want board-certified physician oversight specifically, prefer live video consultations over asynchronous messaging, and have a straightforward testosterone deficiency without other complicating symptoms. It's also the pick if you want quarterly shipments rather than tracking monthly deliveries. See our full PeterMD TRT review for the detailed pricing and process breakdown.

The Bottom Line

Marek Health is the more thorough, more expensive option, and it earns that reputation with genuinely deeper diagnostics and a broader medication menu. Its 8.2 Freak Score reflects real clinical sophistication, not just marketing. PeterMD is the better value for patients with a straightforward case who specifically want the certainty of a board-certified physician and live video access, at roughly $1,000 less per year. Neither clinic is wrong — they're built for different depths of investigation, and the right choice depends on how confident you already are that testosterone is your only problem.

FAQ

Which is cheaper: Marek Health or PeterMD? PeterMD, and by a meaningful margin. Its flat $199/month covers everything, totaling about $2,388/year. A typical Marek patient spends $3,300-$3,900/year once labs, consultations, and medication are added up.

Which has more qualified physicians? Both use licensed medical providers, but PeterMD specifically guarantees board-certified physicians for every patient — a credential you can independently verify through the American Board of Medical Specialties. Marek doesn't market board certification as a blanket standard, though its physicians are qualified to manage hormone therapy.

Which tests more biomarkers? Marek Health, by a wide margin — its panels range from 50 to 130+ biomarkers, compared to PeterMD's initial panel of roughly 11 markers (which is still broader than many budget competitors).

Can I get peptide therapy through PeterMD? Not clearly. PeterMD's public offering centers on testosterone cypionate. Marek Health explicitly offers peptide therapy, including BPC-157, alongside its hormone optimization services.

Is Marek Health worth $1,000+ more per year than PeterMD? Only if you need the diagnostic depth. For a confirmed, straightforward low-T case, PeterMD's board-certified physicians and comprehensive-enough initial panel deliver strong value at a lower cost. For complex or unresolved symptoms, Marek's broader bloodwork is more likely to find the actual root cause.

Can I get enclomiphene or HCG through either provider? Marek offers both as standard options depending on your bloodwork and goals. PeterMD's public offering centers on testosterone cypionate, without a clearly outlined pathway to enclomiphene or HCG — if either of those matters to you, Marek is the safer bet.

Which provider is better for a first-time TRT patient? Both handle first-time patients well, but for different reasons. PeterMD's thorough initial video consultation and comprehensive-enough starter panel make it a solid, lower-friction entry point. Marek is a stronger choice for a first-timer who suspects their symptoms may involve more than testosterone alone, since its broader panel is more likely to catch that on the first pass rather than after a few months of an incomplete protocol.



Affiliate Disclosure: Freak Naturals may earn a commission on purchases made through links in this article. This does not affect our editorial independence — we recommend providers based on research and comparison, not commissions.